Juniper Investment Company, LLC filed an amended statement of changes in beneficial ownership with the SEC on September 23, 2026, disclosing two open-market purchases of Orthofix Medical Inc. common stock totaling 310,000 shares made on September 18 and September 21, 2026.
Key Highlights
- First purchase: 120,000 shares of Orthofix Medical common stock acquired on September 18, 2026, at a weighted average price of $8.7393 per share, with individual trade prices ranging from $8.65 to $8.81.
- Second purchase: 190,000 shares acquired on September 21, 2026, at a weighted average price of $8.8599 per share, with individual trade prices ranging from $8.63 to $8.98.
- Post-transaction holdings: Following both purchases, Juniper Targeted Opportunity Fund, L.P. held 3,771,216 shares indirectly through Juniper Investment Company.
- Additional indirect holdings: Juniper Multi-Strategy Fund, L.P. held 84,926 shares and Juniper Targeted Opportunities, L.P. held 935,901 shares, both indirectly through Juniper Investment Company.
- Reporting persons: Three parties filed jointly: Juniper Investment Company, LLC; John A. Bartholdson; and Alexis P. Michas, each identified as a 10% owner and director of Orthofix Medical Inc.
- Amendment: This filing amends an original statement filed on September 22, 2026.
Juniper Investment Company's Purchases of Orthofix Medical Common Stock
According to the filing, Juniper Investment Company, LLC, a New York-based investment manager, reported two purchases of common stock in Orthofix Medical Inc. (NASDAQ:OFIX), a medical device company. The shares carry a par value of $0.10 per share. The purchases were made through Juniper Targeted Opportunity Fund, L.P., for which Juniper Investment Company serves as investment manager. Both transactions were coded "P," indicating open-market purchases, as reported in Table I of the filing.
The filing identifies John A. Bartholdson and Alexis P. Michas as managing members of Juniper Investment Company and as general partners of each of the three affiliated funds - Juniper Targeted Opportunity Fund, L.P., Juniper Multi-Strategy Fund, L.P., and Juniper Targeted Opportunities, L.P. As a result, the filing states that Messrs. Bartholdson and Michas "share voting and dispositive power over such shares with Juniper Investment Company." Each individual, as well as Juniper Investment Company itself, disclaims beneficial ownership of the reported holdings "except to the extent of its pecuniary interest therein," according to the filing's explanatory footnotes.
The filing notes that Juniper Investment Company undertakes to provide details of the individual trades within each weighted-average-price transaction to Orthofix Medical or the SEC upon request. No derivative securities transactions were reported in Table II of this filing. All reported ownership is indirect, held through the three named limited partnerships.
What Was Disclosed
Juniper Investment Company, LLC and affiliated individuals disclosed two open-market purchases totaling 310,000 shares of Orthofix Medical Inc. common stock on September 18 and September 21, 2026, bringing the Juniper Targeted Opportunity Fund's reported indirect holding to 3,771,216 shares.



Please wait processing your request...